Human embryonic stem cells: International policy and regulation

Megan Allyse, Stephen Minger

Research output: Chapter in Book/Report/Conference proceedingChapter


Although human embryonic stem cells may have enormous potential for the treatment of degenerative diseases, their origins and derivation have raised unprecedented controversy in many societies. Many organisations, on both international and national levels, have responded with regulatory systems that seek to manage and supervise such work. These systems vary from voluntary professional guidelines and international treaties to government agencies and binding national legislation. This chapter briefly summarises the main controversies surrounding human embryonic stem cell research and the existing international mechanisms that address its conduct. We then offer a more detailed overview of the relevant regulatory structures of five nations — the US, the UK, China, India and South Korea — where research with human embryonic stem cells is commonly practiced. A review of the responsible state and professional bodies in each country is included, along with a brief discussion of any relevant legislation. Regulations relevant to the conduct of international collaboration with national research groups are included where possible.

Original languageEnglish (US)
Title of host publicationAdvances in Tissue Engineering
PublisherImperial College Press
Number of pages20
ISBN (Electronic)9781848161832
ISBN (Print)9781848161825
StatePublished - Jan 1 2008
Externally publishedYes


  • Chimera
  • Cytoplasmic Hybrid
  • Ethics Committee
  • Informed Consent
  • International Collaboration
  • Nuclear Transfer
  • Somatic Cell

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Human embryonic stem cells: International policy and regulation'. Together they form a unique fingerprint.

Cite this